WSFS
LKFT

Wilmington Savings Fund Society’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Wilmington Savings Fund Society’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-36
Closed -$1.08K – 1520
2026
Q1 		$1.08K Hold
36
– – ﹤0.01% 1387
2025
Q4 		$1.18K Buy
+36
New +$1.16K ﹤0.01% 1341
2025
Q3 		– Sell
-74
Closed -$2.07K – 1650
2025
Q2 		$2.07K Hold
74
– – ﹤0.01% 1903
2025
Q1 		$1.86K Hold
74
– – ﹤0.01% 1926
2024
Q4 		$2.04K Hold
74
– – ﹤0.01% 1936
2024
Q3 		$2.13K Buy
+74
New +$2.02K ﹤0.01% 1906

Other funds holding LKFT

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
DO
denkapparat Operations Berlin, Germany $306M AUM 40.46% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Wilmington Savings Fund Society's LKFT Position: Q2 2026 in Review

Wilmington Savings Fund Society sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q2 2026, closing a stake of 36 shares — an estimated $1.08K sold.

Wilmington Savings Fund Society first reported a position in LKFT in Q3 2024 and held it in 6 quarters. The position peaked at $2.13K in Q3 2024. 24 funds tracked by Wall St. Rank hold LKFT as of Q2 2026.

  • Wilmington Savings Fund Society reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q2 2026 after selling out during the quarter.
  • Wilmington Savings Fund Society sold 36 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2026, an estimated $1.08K.
  • Wilmington Savings Fund Society first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2024 and held it in 6 quarters.
  • Wilmington Savings Fund Society's Lakefront Biotherapeutics American Depositary Shares position peaked at $2.13K in Q3 2024.
  • 24 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2026.

Based on Wilmington Savings Fund Society's 13F filing for Q2 2026, filed 28 Jul 2026.